Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Abroad (travel likely)RecruitingPHASE1
Conditions
Peritoneal Mesothelioma · Peritoneal Carcinomatosis · Ovarian Cancer · Gastrointestinal Cancer · Appendiceal Cancer · Atypical Mesothelial Proliferation · Colorectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact National Cancer Institute Referral Office) · 888-624-1937
Study leads
Andrew M Blakely, M.D.
Principal Investigator
National Cancer Institute (NCI)